We are developing therapies that selectively target multi resistant pathogenic bacteria or modulate a microbiome which will have the potential to transform the lives of people with severe infectious diseases, autoimmune disorders and cancer. We are committed to continuing to develop CRISPR technologies and capabilities that have broad potential beyond the core indications.
We are actively seeking collaborators and licensing opportunities both globally and in the U.S., Europe and Asia to explore the therapeutic potential of our transformational CRISPR technologies in new bacterial targets and diseases.
If you would like additional commercial partnering information, contact us at: email@example.com
Academic partnering and research
If you would like additional academic partnering information, contact us at: firstname.lastname@example.org